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Summary. Sinovitis in Scleroderma (SSc) is rare,
usually aggressive and fully resembles rheumatoid
arthritis. Experimental models of SSc have been used in
an attempt to understand its pathogenesis. Previous
studies done in our laboratory had already revealed the
presence of a synovial remodeling process in rabbits
immunized with collagen V. To validate the importance
of collagen type V and to explore the quantitative
relationship between this factor and synovia remodeling
as well as the relationship between collagen type V and
other collagens, we studied the synovial tissue in
immunized rabbits. Rabbits (N=10) were immunized
with collagen V plus Freund’s adjuvant and compared
with animals inoculated with adjuvant only (N=10).
Synovial tissues were submitted to histological analysis,
immunolocalization to collagen I, III and V and
biochemical analysis by eletrophoresis, immunoblot and
densitometric method. The synovial tissue presented an
intense remodeling process with deposits of collagen
types I, III and V after 75 and 120 days of immunization,
mainly distributed around the vessels and interstitium of
synovial extracellular matrix. Densitometric analysis
confirmed the increased synthesis of collagen I, III and
V chains (407.69±80.31; 24.46±2.58; 70.51±7.66,
respectively) in immunized rabbits when compared with
animals from control group (164.91±15.67; 12.89±1.05;
32±3.57) (p<0.0001). We conclude that synovial
remodeling observed in the experimental model can
reflect the articular compromise present in patients with
scleroderma. Certainly, this experimental model induced
by collagen V immunization will bring new insights in
to pathogenic mechanisms and allow the testing of new
therapeutic strategies to ameliorate the prognosis for
scleroderma patients.
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Introduction
Sinovitis in SSc is rare, usually aggressive and fully
resembles rheumatoid arthritis. In all other cases sinovial
fibrosis is due to time fibrosis and progressive retraction
of the fingers. Experimental models of SSc have been
used in an attempt to understand its pathogenesis, but
most of these models are obtained from genetically
modified animals, such as naturally-occurring TSK-1
(Saito et al., 2002), UCD-200 chickens (Sgonc, 1999) or
genetically manipulated animals through mutagenesis or
genetic modifications (Clark, 2005). Scleroderma-like
lesions are also observed following chemical exposure to
bleomycin (Yamamoto and Nisshioka, 2005) or
transplantation of immune cells originating a graft-
versus-host disease (GVHD) (Zhang and Gilliam, 2002).
In all of these models the sinovial changes are minimal
or absent. 
Recently, we discovered a novel experimental model
that reproduces most of the histological aspects of
scleroderma, induced in healthy female New Zealand
rabbits, after animal immunization with human type V
collagen (col V) plus Freund’s adjuvant. These animals
develop progressive fibrosis and vasculitis of all organs
normally affected in this disease, including skin,
esophagus, heart, synovia, cartilage and kidney
(Yoshinari et al., 2002; Teodoro et al., 2003, 2004;
Bezerra et al., 2006). 
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Histology and
Histopathology
Cellular and Molecular Biology
Collagen V is a component of the basement
membrane, synovial screen, hyaline articular cartilage,
and placenta and surrounds vascular smooth muscular
cells (Niyibizi et al., 1984; Linsenmayer et al., 1990;
Hay, 1991; Adachi et al., 1997). Some particularities
make collagen V different from the other types. The
molecule maintains the NH2 and COOH terminal ends
making it more immunogenic (Linsenmayer et al., 1990;
Hay, 1991). Otherwise, collagen type V is not normally
exposed in the tissues, because it is found between
collagen types I and III, composing heterotypic fibers,
except in the cornea (Niyibizi et al., 1984; Lisenmayer et
al., 1990). Type V collagen has also been found to be
involved in the pathogenesis of experimental lung
allograft rejection (Haque et al., 2002; Yasufuku et al.,
2002; Wilkes, 2003). Others authors have prevented
bronchiolitis obliterans in rat lung allografts by type V
collagen-induced oral tolerance (Yasufuku et al., 2001).
Collagen V plays an important role in the proliferation
process and tissue remodeling (Leroy et al., 1996;
Mckown et al., 2000). Interaction of collagen type V
with type I originate heterotypic fibrils, implicated in
keeping the integrity of ECM and regulating collagen
fibril diameter (Adachi and Hayachi, 1986; Burrows et
al., 1996; Michalickova et al., 1998; Birk, 2001).
Collagen types I and V heterotypic fibers mask the
helical region of type V molecule, becoming epitopes of
this region hidden and inaccessible. Otherwise, retention
of a large part of the N-propeptide in mature molecules
makes it more immunogenic (Linsenmayer et al., 1990;
Andrikopoulos et al., 1995). 
Previous studies done in our laboratory had already
revealed the presence of a synovial remodeling process
in rabbits immunized with collagen V (Bezerra et al.,
2006). To validate the importance of collagen type V and
to explore the quantitative relationship between this
factor and synovia remodeling as well as the relationship
between collagen type V and other collagens, we studied
the synovial tissue in immunized rabbits and herein
report our results. 
Materials and methods
Experimental protocol
The experimental protocol was described in previous
papers (Teodoro et al., 2003, 2004). Briefly, female New
Zealand rabbits (N=10) with similar age and weight
(2,500g) were immunized subcutaneously with 1 mg
collagen type V isolated from human placenta, extracted
by precipitation with sodium chloride, diluted in 1 ml 10
mM acetic acid and added to an equal volume of
complete Freund’s adjuvant. The antigen specificity was
tested by immunoblotting using monoclonal antibodies
against collagen types I, III and V.
Four weeks later, rabbits received an identical dose
of type V collagen, and two booster immunizations were
administered intramuscularly, separated by a 15-day
interval (1 mg type V collagen plus 1ml incomplete
Freund’s adjuvant). Each group of immunized animals
was compared to the control group (N=10), inoculated
with 10 mM acetic acid in complete or incomplete
Freund’s adjuvant and the samples were obtained 75 and
120 days after the first immunization. 
The synovia was removed under strictly sterile
conditions, and samples were immersed in 10% formalin
for 24 hours and embedded in paraffin. Two to 3 µm-
thick sections were stained by Masson’s trichrome and
examined under a Nikon light microscope. All slides
were coded, randomized, and then examined by three
observers (LO, WT and VLC), who did not have access
to the code.
Collagen immunodetection 
Immunofluorescence of synovia samples was done
in paraffin-embedded fragments mounted on slides with
aminosylane (Sigma Chemical Co.; St. Louis, Missouri,
USA) for collagen characterization. The slides were
immersed in xylene and dehydrated in decreasing
ethanol concentrations. The immunogenic sites were
exposed by enzymatic treatment of the synovia samples
with bovine pepsin (10,000 UTD; Sigma Co.; St. Louis,
Missouri, USA) in 2 mg/ml acid buffer, pH 2.2, for 30
min at 37°C, followed by incubation in phosphate-
buffered 5% milk, pH 7. The slides were incubated
overnight at 4°C with polyclonal anti-collagen types I
and V antibodies obtained from mice and diluted at 1:25
in phosphate-buffered saline (PBS) (Teodoro et al.,
2004), and with monoclonal anti-collagen type III
(Oncogen; San Diego, USA) diluted at 1:100. The slides
were washed several times in PBS-0.05% Tween 20 and
incubated for 90 min with secondary antibody
(fluorescein conjugated mouse anti-IgG, Sigma; St.
Louis, Missouri, USA) diluted 1:50 in PBS containing
0.005% Evans blue. The slides were again washed
several times in PBS-0.05% Tween 20 and mounted with
buffered glycerin. The reaction was visualized under a
Nikon fluorescence microscope.
Collagen biochemical characterization
For extraction of synovia collagen the tissue samples
were sliced in EDTA and proteinase inhibitors (50 mM
EDTA, 5 mM phenylmethylsulfonyl fluoride and 0.02
mM N-ethylmaleimide) and washed for 48 hours at 4°C.
The samples were homogenized with a Teckman
polytron and submitted to a 12000 rpm centrifugation for
30 minutes. The residue was treated with pepsin
(substrate/enzyme 10:1) in 0.5 M acetic acid at 4°C for
16 h. The reaction mixture was neutralized to pH 8.0 and
left overnight at room temperature to inactivate pepsin.
Collagen was precipitated by adding NaCl 2 M. The
collagen chains were analyzed by SDS-PAGE (7.5%)
with reduction by 2-mercaptoethanol according to the
methods described by Laemmli (1970) and Sykes et al.
(1971). After performing SDS-PAGE of collagen
samples, proteins migrated in the gel were electro-
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transferred onto a nitrocellulose membrane (Sigma
Chemical Co.) The membrane was blocked in 5%
skimmed milk/PBS for 1 h at room temperature, and the
immunoreaction was performed by incubation with
mouse monoclonal anti-collagen type I (Sigma Chemical
Co.), mouse monoclonal anti-human type III collagen
(Oncogen; San Diego, USA) and rabbit polyclonal anti-
human type V collagen according to Teodoro et al.
(2004). The collagen chains were evaluated by
densitometric method in Image Master VDS (Pharmacia
Biotech).
Statistical analysis
To test our hypothesis about the influence of
collagen V autoantibody on the pathogenesis of the
disease we compared the results obtained from
immunized and control animals. We assessed differences
and associations in the frequency of densitometric
variables by the T-test for independent samples. The
statistical procedure was performed with SPSS version
10.0 statistical software (SPSS, 2002).The level of
statistical significance was set at p<0.05.
Results
Synovial architecture and extracellular matrix
Remodeling (ECM) in control and immunized rabbits
Figure 1 (Panels A to H) shows the morphologic
features of synovial tissue obtained from control and
immunized animals, stained with H&E and Masson’s
trichromic. Qualitative analysis of the H&E-stained and
Masson’s trichromic section of the control groups
showed preserved architecture, without inflammatory or
repair tissue response in any of the synovial
compartments (Fig. 1A-D). In contrast, the subsynovial
compartment of immunized animals was characterized
by thickening of the connective tissue frame and vessel
walls (Fig. 1E,F). 
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Fig. 1. Synovia obtained from rabbits of controls
(A-D) and immunized groups (E-H), stained with
H&E (A, B, E, F) and Masson’s trichrome (A, D,
G, H). The control group showed maintenance of
normal architecture, without inflamatory or repair
tissue response. The immunized group (E-H)
showed thickening of connective tissue in
sinovial tissue (arrows) without cellular
inflammatory response. (COL: collagen).
Collagen changes in synovial ECM of control and
immunized rabbits 
Figure 2A-H shows the collagen fibers in synovial
ECM from control and immunized rabbits,
immunostained with types I, III and V collagen and
observed using immunofluorescence. Figure 2A,C and E
show the synovia from the control rabbits clearly
exhibiting the weak fine and fibrilar fluorescent green
birefringence for types I, III and V collagen, in synovial
(S) and subsynovial (SS) connective frame. The
immunofluorescence pattern of types I, III and V
collagen is coincident with the preserved architecture
observed in normal synovial ECM (Fig. 1A-D). Figures
2B, 2D show the synovia from the immunized rabbits
exhibiting strong birefringence for types I and III
collagen due to thickening and histoarchitectural
distortion, involving the synovial connective frame and
ECM of small vessels (Fig. 2B,D). Interesting enough
was the high expression of type V collagen, causing
diffuse thickening of the synovial connective frame (Fig.
2F) when compared to controls (Fig. 2E). Furthermore, a
coexistence of type I and type V collagens was found to
determine the thickening of the ECM periadventitial of
small vessels (Fig. 2G,H). These alterations were more
evident after 120 days of type V sensitization, which was
coincident with the modifications discussed at H&E
stain (see Fig. 1E-H). To confirm specificity of the
staining, some representative control sections were
incubated with total serum of rabbits. 
Biochemical measurement of types I, III and V
SDS-PAGE profile of pepsin-soluble collagen
fractions 2.5 M NaCl-precipitated from synovia of
immunized and control rabbits is shown in Figure 3.
Types I and III collagen were identified in the presence
of ß-mercaptoethanol and urea, presenting bands with
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Fig. 2. Immunofluorescence to types I, III and V
collagen in synovia section of control and
immunized rabbits. The control group shows a
weak fine and fibri l lar f luorescent green
birefringence for type I (A), III (C) and V (E)
collagen in synovial and subsynovial connective
frame. The immunized rabbits showed a strong
birefringence for types I (B, G) and III (D) in
subsynovial connective frame and ECM of small
vessels. Note the high expression of type V
collagen causing diffuse thickening of
subsynovial connective frame compared to
control (E, F) and the diffuse thickening of the ECM periadventitial of small vessels with collagen I (G) and V (H).
molecular masses of 108, 97 and 84 Kd, corresponding
respectively to α1(III), α1(I) and α2(I) chains, in
synovia from control and immunized rabbits (Fig. 3A).
Type V collagen α [α1(V), α2(V) and α3(V)] chains
were observed around 116Kd by SDS-PAGE
electrophoresis without urea (Fig. 3B). Immunoblotting
analysis using specific antibodies confirmed the
electrophoretic motility of types I, III and V collagen
chains in synovia samples from immunized and control
rabbits (Fig. 3C).
The amount of types I, III and V collagen α-chains
isolated from synovia of experimental groups and
controls was determined by densitometry. The statistical
analysis of the densitometric results revealed increased
amounts of collagen types I, III and V (407.69±80.31;
24.46±2.58; 70.51±7.66) when compared with the
control group (164.91±15.67; 12.89±1.05; 32±3.57)
(p<0.0001) (Fig. 3D).
Discussion
In this study, histoarchitectural changes of interstitial
and vascular extracellular matrix characterized the
remodeling process of the synovia in the presence of a
poor inflammatory response after 120 days of rabbit
immunization with human collagen type V (col V).
Immunofluorescence and biochemical analysis
confirmed collagen types I, III and V deposits at
synovial extracellular matrix. These findings are very
similar to histological changes found in human synovia
of patients with scleroderma. In both cases, the presence
of important remodeling and scarce inflammatory
process are common features (Bezerra et al., 2006).
Interestingly, the immunodetection of collagen type V at
the synovial tissue showed the same abnormal
expression of this molecule, similarly to those previously
observed in lung and skin of animals and patients with
systemic sclerosis (Teodoro et al., 2004; Bezerra et al.,
2006). Specifically, increased quantities of structurally
different collagen V were found distributed in the
subsynovial connective tissue and vessels, forming thick
fibers with a network aspect, causing histoarchitectural
distortion of the extracellular matrix. In general, this
molecule displays discrete labelling, forming long and
slim fibrils, composing heterotypic fibers with collagen
types I and III (Adachi and Hayashi, 1986). 
The above results confirm the relevance of this novel
experimental model, induced in healthy animals,
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Fig. 3. Collagen types I and III
fractions in SDS-PAGE profile
of immunized and control
rabbits identified in the
presence of b-
mercaptoethanol and urea (A)
and collagen type V fractions
identified in the presence of b-
mercaptoethanol without urea
(B). Immunoblotting shows
types I, III and V collagen in
control and immunized
animals (C). Graph obtained
after densitometric
quantification of types I, III
and V collagen shows
increased amount of collagen
types I, III and V in immunized
animals compared with
control group (D).
following col V immunization, since it reproduces
similar histological abnormalities seen in scleroderma in
all organs studied until now, including sinovial tissue.
Also, the overexpression of abnormal collagen type V
was a common feature observed in animals and patients,
suggesting the existence of a final common pathogenic
pathway between the experimental model and patients
with scleroderma (Bezerra et al., 2006).
We speculate the existence of at least two
complementary pathways, responsible for inflammatory
and remodeling processes, viewed in rabbits immunized
with col V. Probably, the mechanism is related to direct
binding of collagen V epitopes on endothelial cells,
enhancing synthesis of collagen by fibroblasts or
myofibroblasts. Prolonged attack can provoke basement
membrane injury and exposition of hidden collagen V
epitopes, originating neoantigens, which will trigger an
auto-immune disease. The presence of this pathway may
be corroborated by the presence of persistent circulating
immunocomplexes and the appearance of antibodies to
collagen types IV and continuous presence of antibodies
to collagen V in the sera of immunized rabbits. 
Our results are supported by previous studies in
atherosclerosis. Underwood et al. (1998), demonstrated
in an experimental study that collagen type V secreted
into the ECM by human intimal vascular smooth muscle
cells in culture, is inhibitory for adhesion and
proliferation of endothelial cells isolated from the
umbilical artery. Moreover, previous studies had
demonstrated the cessation of endothelium recovery,
following endothelia cell damage, observed during any
surgical procedure in an attempt to alleviate arterial
stenosis (Shirotani et al., 1993; Rogers and Edelman,
1995). The reason for such inhibition was suggested by
the formation of a neointima secreted by smooth muscle,
which was rich in inhibitory factors, including collagen
type V (Ziats and Anderson, 1993). These studies
suggested an important role for col V in the inhibition of
endothelium recovery after vascular injury. We postulate
that in our experimental model, similar pathogenic
mechanisms are present. 
Synovia remodeling present in this experimental
model probably mimicks the articular compromise
observed in patients with SSc. Previous studies done in
our laboratory had already revealed the presence of a
synovial remodeling process in rabbits immunized with
collagen V (Teodoro et al., 2003). Studies on synovial
tissue are of great interest in rheumatology, since joint
symptoms are frequent and in general, each rheumatic
disease presents particular clinical and histological
aspects, helping to discriminate a given disease. There
are few studies on synovia tissue in scleroderma and
some questions have intrigued researchers. For example,
how is it possible for the same pathogenic mechanism
responsible for disease setting to promote distinct
histological presentations in different organs? Lung
involvement in the active stage of scleroderma patients
is characterized by the presence of a remarkable
inflammatory process, while the remodeling process
with discreet cell infiltration, is observed in synovial
tissue. 
The next question is to understand the remodeling
process in the presence of a poor inflammatory response
observed in synovia of the immunized rabbits. It is
possible that collagen V isoform found in synovia could
be different from that found for example in lung, or the
quantitative expression of collagen V is minor in
synovia, when compared with those seen in other organs.
It is known that synovial cells are not supported by
basement membrane, which is an important source of
collagen V molecules.
We conclude that synovial remodeling observed in
the experimental model can reflect the articular
compromise present in patients with scleroderma,
overexpression of abnormal collagen type V being a
common feature in both conditions. Certainly, this
experimental model induced by collagen V
immunization will bring new insights in to pathogenic
mechanisms and allow the testing of new therapeutic
strategies to ameliorate the prognosis for scleroderma
patients.
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